Chimerix inc

Major-Pharmaceuticals

CMRX


2505 Meridian Parkway
Durham , NC 27713

Executive/
Director

Price

  • Last Close
  • $ 0.96
    $ -0.04 -4.4 %
    Aug 29, 2024
  • 52-Week High/Low
  • $1.26 - $0.77
  • YTD
  • -0.7%

  • Trading Volume
  • 1,826
  • Market Cap Full
  • $ 85.3M
  • Shares Outstanding
  • 88.9M
    Oct 27, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -6.4% -42.9% 38.7% 12.3% -18.3% -5% 98.1% -27.9% -32.3% 10.1%
Q2 22.6% -23.1% -14.6% -1.7% 80.3% 4% -16.4% -55.1% -4% -3.8%
Q3 -17.3% 41% -3.7% -19.5% -40.2% 8% -23.8% -7.2% -20.7% -
Q4 -76.6% -17% -14.1% -31.3% -17.8% 94% 5.4% -3.6% -1% -
J F M A M J J A S O N D
2024 -2.8% 22.9% -7.8% -4.7% - - - - - - - -
2023 -4.8% -10.7% -20.3% -7.9% 19% -12.3% -2.5% -3.4% -15.8% -1.9% 3.3% -1%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    166%-78%-49%1%-44%-21%138%33%-71%-48%-1%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.54 0.57 0.38 -0.42 -0.35 -0.17 -1.21 -0.28 -0.24
Q2 0.59 0.39 0.36 -0.39 -0.35 -0.16 -0.21 -0.27 -0.21
Q3 0.70 0.37 0.37 -0.33 -1.26 -0.18 -0.21 2.75 -0.27
Q4 0.82 0.32 0.41 -0.29 -0.07 -0.19 -0.41 -0.26 -
A 2.7 1.7 1.5 -1.4 -2 -0.7 -2 1.9 -0.72

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 50.9 61.7 85.7 87 88.3
Jun 47.8 51.1 61.9 86.2 87.4 88.6
Sep 48 61.3 62.2 86.2 87.6 88.6
Dec 50.7 61.4 62.6 86.9 88 88.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.7 1 - 13 7
Total Asset Turnover 0.1 - 0.1 0.1 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 0.3 - 45 38.7 24
Equity multiplier 0.2 - - - -